First-Line Treatment for Acute Strep Pharyngitis
Penicillin or amoxicillin for 10 days is the first-line treatment for acute Group A streptococcal pharyngitis in patients without penicillin allergy 1.
Primary Treatment Recommendation
The 2012 IDSA guideline establishes penicillin and amoxicillin as the drugs of choice based on their:
- Narrow spectrum of activity
- Low frequency of adverse reactions
- Modest cost
- Strong evidence supporting their efficacy (strong recommendation, high-quality evidence) 1
The standard treatment duration is 10 days to ensure eradication of the organism from the pharynx 1.
For Penicillin-Allergic Patients
The treatment algorithm depends on the type of allergy 1:
- Non-anaphylactic penicillin allergy: First-generation cephalosporin for 10 days
- Anaphylactic or severe allergy:
- Clindamycin for 10 days, OR
- Clarithromycin for 10 days, OR
- Azithromycin for 5 days
Critical Caveat About Azithromycin
Azithromycin should be avoided when possible due to emerging evidence of inferior efficacy. A 2026 network meta-analysis of 64 RCTs found azithromycin demonstrated:
- Significantly worse early bacterial eradication compared to penicillin V (OR 0.53)
- Inferior late bacterial eradication (OR 0.38)
- Higher late recurrence rates
- Increased adverse events 2
This represents important new data that challenges azithromycin's position even as an alternative agent, though it remains in guidelines for patients with true penicillin anaphylaxis where options are limited.
Evidence Supporting Penicillin as First-Line
Recent research continues to validate penicillin's role. The 2026 network meta-analysis concluded that "standard penicillins should remain the preferred first-line therapy for GAS pharyngitis to support antimicrobial stewardship" 2. A 2016 Cochrane review found no clinically relevant differences in symptom resolution between cephalosporins or macrolides compared to penicillin, supporting penicillin's continued use given its low cost and absence of resistance 3.
Alternative Considerations
While cephalosporins showed some advantages in specific outcomes (cefdinir and cefpodoxime for early bacterial eradication; cefprozil for late eradication) 2, these marginal benefits do not justify routine use over penicillin given antimicrobial stewardship principles and the need to preserve broader-spectrum agents 1, 2.
Adjunctive Symptomatic Treatment
Beyond antibiotics, the IDSA guideline recommends 1:
- NSAIDs or acetaminophen for moderate to severe symptoms or high fever (strong recommendation, high-quality evidence)
- Avoid aspirin in children (strong recommendation, moderate-quality evidence)
- Do not use corticosteroids routinely (weak recommendation, moderate-quality evidence)
Common Pitfalls to Avoid
Prescribing broad-spectrum antibiotics unnecessarily: Despite evidence supporting narrow-spectrum agents, broad-spectrum antibiotics continue to be overprescribed in clinical practice 2
Treating without confirmation: Approximately 60% of adults with sore throat receive antibiotics despite only 10% having GAS pharyngitis 4. Always confirm diagnosis with rapid antigen testing or throat culture before treating
Shortening treatment duration: The full 10-day course is necessary for bacterial eradication, even if symptoms improve earlier 1
Using azithromycin as a routine alternative: Reserve this only for patients with true anaphylactic penicillin allergy given its inferior efficacy profile 2